This proposal is directed at determining the molecular mechanisms by which tolerance develops to anxiolytic actions of ethanol. The understanding of the mechanisms of tolerance development will provide information that should assist in the understanding of the motivation driving increased ingestion of alcohol. Our research design will utilize genetically-modified animals which carry a modification in an enzyme in their brains through which alcohol can exert its action (i.e., adenylyl cyclase). The transgenic mice and their """"""""wild-type"""""""" littermates will be treated acutely and chronically with ethanol. We will study the effect of drug administration on the animals' levels of anxiety and changes in drug response over a period of chronic drug administration. We will also monitor environmental influences on drug response after chronic ethanol treatment. Simultaneously, we will monitor the function and changes in function of intraneuronal signalling systems that control gene transcription. Finally, we will use gene- expression arrays to monitor which genes are modulated in the short- term and long-term by ethanol administration and which genes are related to tolerance development. In all, our studies should provide an excellent foundation for understanding the neuroadaptive processes leading to ethanol tolerance in reference to the anxiolytic action of this drug.

Agency
National Institute of Health (NIH)
Institute
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01AA013489-05
Application #
6941308
Study Section
Special Emphasis Panel (ZAA1-DD (20))
Program Officer
Sorensen, Roger
Project Start
2001-09-27
Project End
2007-08-31
Budget Start
2005-09-01
Budget End
2007-08-31
Support Year
5
Fiscal Year
2005
Total Cost
$594,784
Indirect Cost
Name
University of Colorado Denver
Department
Pharmacology
Type
Schools of Medicine
DUNS #
041096314
City
Aurora
State
CO
Country
United States
Zip Code
80045
Logrip, Marian L; Janak, Patricia H; Ron, Dorit (2009) Escalating ethanol intake is associated with altered corticostriatal BDNF expression. J Neurochem 109:1459-68
Lasek, A W; Janak, P H; He, L et al. (2007) Downregulation of mu opioid receptor by RNA interference in the ventral tegmental area reduces ethanol consumption in mice. Genes Brain Behav 6:728-35
Kamdar, N K; Miller, S A; Syed, Y M et al. (2007) Acute effects of naltrexone and GBR 12909 on ethanol drinking-in-the-dark in C57BL/6J mice. Psychopharmacology (Berl) 192:207-17
Hines, Lisa M; Hoffman, Paula L; Bhave, Sanjiv et al. (2006) A sex-specific role of type VII adenylyl cyclase in depression. J Neurosci 26:12609-19
Bhave, Sanjiv V; Hoffman, Paula L; Lassen, Natalie et al. (2006) Gene array profiles of alcohol and aldehyde metabolizing enzymes in brains of C57BL/6 and DBA/2 mice. Alcohol Clin Exp Res 30:1659-69
Sikela, James M; Maclaren, Erik J; Kim, Young et al. (2006) DNA microarray and proteomic strategies for understanding alcohol action. Alcohol Clin Exp Res 30:700-8
Mulligan, Megan K; Ponomarev, Igor; Hitzemann, Robert J et al. (2006) Toward understanding the genetics of alcohol drinking through transcriptome meta-analysis. Proc Natl Acad Sci U S A 103:6368-73
Matthews, Douglas B; Bhave, Sanjiv V; Belknap, John K et al. (2005) Complex genetics of interactions of alcohol and CNS function and behavior. Alcohol Clin Exp Res 29:1706-19
Donohue, Timothy; Hoffman, Paula L; Tabakoff, Boris (2005) Effect of ethanol on DARPP-32 phosphorylation in transgenic mice that express human type VII adenylyl cyclase in brain. Alcohol Clin Exp Res 29:310-6
Verkhusha, Vladislav V; Sorkin, Alexander (2005) Conversion of the monomeric red fluorescent protein into a photoactivatable probe. Chem Biol 12:279-85

Showing the most recent 10 out of 12 publications